Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

20191,186 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 394, Issue 10215, pp. 2184-2196

Field-Weighted Citation Impact: 99.27